Drugs / Udonitrectag
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04276558 | Oct 2020 → Apr 2024 | neurotrophic keratopathy | RECORDATI GROUP | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Udonitrectag | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04276558 ↗ |
| Known as | REC-0559 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594439 ↗ |
| Modality | Small molecule | — CHEMBL4594439 ↗ |
| Route | Topical | “Eye drop solution in single dose unit.” NCT04276558 ↗ |